Drug Overdose Prevention Information

Having trouble viewing this email? View it as a Web page.

PDO email header

April 16, 2019

Here are your weekly opioid epidemic updates from the Indiana State Department of Health:

China places tighter restrictions on fentanyl, thereby decreasing supply of the drug to the United States


2 milligrams of Fentanyl, a lethal dose for most people.

China has announced it would declare all forms of fentanyl as controlled substances, thus strictly regulating their production and distribution within the country. American officials say that a large majority of the fentanyl in the United States comes from China, so this move could lower the supply of the drug here. However, the ban does not cover all precursor chemicals used to make fentanyl and other similar drugs. These chemicals are often shipped to Mexico from China in small quantities and used to produce fentanyl shipped to the United States.

Indiana State Medical Association launches opioid-focused podcast series

The Indiana State Medical Association (ISMA) has recently launched an opioid-focused podcast series featuring leading clinicians who put essential information about opioid prescribing and addiction at your fingertips. Physicians may choose from topics such as conversations with difficult patients, how the opioid crisis began and where it stands now, tapering patients off opioids and more. Physicians who listen to the podcasts can earn continuing medical education (CME) credits as part of the statewide requirement for physicians licensed to prescribe controlled substances.

Intersection between traumatic brain injury and opioid use disorder: Recommendations for substance use treatment providers

Traumatic brain injury (TBI) is common among people who have a substance use disorder. More than 20 percent of non-institutionalized adults in the United States have had at least one TBI with a loss of consciousness. This estimate more than doubles among people with substance use disorder, according to the INROADS Project ― or Intersecting Research on Opioid Misuse, Addiction, and Disability Services ― a joint research program between Brandeis University’s Institute for Behavioral Health and Lurie Institute for Disability Policy. Individuals with co-occurring substance use disorders and mental health problems are even more likely to have a history of TBI. This factsheet includes recommendations for substance use treatment providers, including strategies for determining the unique needs of clients and strategies to address specific executive functioning problems.

Implantable naltrexone may improve outcomes in patients with HIV and opioid use disorder

According to a recent study, an implantable form of naltrexone, a drug used in medication-assisted treatment, may be useful in treating opioid use disorder for people living with HIV. Opioid addiction can make it difficult for people with HIV to continue taking their anti-viral medications. The study found that patients with the naltrexone implant were more likely to be adherent to their medications, resulting in a decreased viral load compared to patients who were taking an oral form of naltrexone for opioid addiction. While further research is required, this is a promising option for patients who live in areas where treatment options are limited.

Follow us! @INDTrauma


Check out our website

world wide web logo
light blue divider


light blue divider

Webcast: Effective Implementation of RNR in Treatment Court Settings

April 22, 1:30pm EDT
The Risk-Need-Responsivity (RNR) principles have applications that benefit both criminal justice and behavioral health practitioners. This webinar will cover implementation of the RNR model, focusing on effective integration of RNR principles in treatment court settings. Presenters will provide an overview of the importance of RNR, different types of tools available, and specific considerations for treatment court professionals. Register here.

light blue divider

10th Annual Minority Health Conference: Minorities & Addiction

April 30, 9:00am-4:00pm
The theme of this year's Minority Health Conference will focus on addiction and how treatment, programming, and resources affect race and culture in Indiana. Register here.

light blue divider

SBIRT Training

Various dates and locations
ISDH, in partnership with Prevention Insights, is hosting Screening, Brief Intervention and Referral to Treatment (SBIRT) sessions at three locations this year. Follow the link below to register at the location of your choice.
Howard County
Wayne County
Scott County  

light blue divider

Second Annual SEOW Symposium

May 17, 8:00am-2:00pm
The Indiana State Epidemiological Outcomes Workgroup (SEOW) Symposium highlights research and initiatives in the substance use and mental health fields. It provides a forum for prevention professionals, coalition leaders, researchers, and state partners to share their knowledge, and to engage in networking opportunities. Register here.

light blue divider

Ann Daugherty Symposium for Basic Science of Addiction and Treatment

May 22, 8:00am-4:30pm
This conference is a forum for professionals, policymakers, educators and the public from diverse disciplines interested in the biochemical, genetic, behavioral, and public health aspects of addiction. Register here.